3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Leukemia, Myeloid, Acute
23
Burkitt Lymphoma
12
Myelodysplastic Syndromes
7
Precursor Cell Lymphoblastic Leukemia-Lymphoma
5
Myeloproliferative Disorders
5
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma
4
Lymphoma, Non-Hodgkin
3
Lymphoma, Mantle-Cell
3
Leukemia, Biphenotypic, Acute
3
Leukemia
3
Blast Crisis
3
Sarcoma, Myeloid
2
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
2
Lymphoma, Follicular
2
Leukemia, Myelomonocytic, Chronic
2
Down Syndrome
2
Recurrence
1
Plasmablastic Lymphoma
1
Lymphoma, T-Cell
1
Lymphoma, Large B-Cell, Diffuse
1
Lymphoma
1
Leukemia, Promyelocytic, Acute
1
Leukemia, Myeloid, Accelerated Phase
1
Leukemia, Myeloid
1
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
1
Hodgkin Disease
1
Hematologic Neoplasms
1
HIV Infections
1
Acute Myeloid Leukemia With KMT2A Rearrangement
1
Interventions
Temozolomide
6
Radiosurgery
6
pembrolizumab
4
Magnetic Resonance Spectroscopy
4
Bevacizumab
4
Specimen Handling
3
Nivolumab
3
abemaciclib
2
Watchful Waiting
2
Surveys and Questionnaires
2
Receptors, Interleukin-8B
2
Radiation
2
Mental Status and Dementia Tests
2
Memantine
2
Ipilimumab
2
Biopsy
2
vorasidenib
1
sotorasib
1
sapanisertib
1
ribociclib
1
pertuzumab
1
osimertinib
1
lenvatinib
1
fluciclovine F-18
1
entrectinib
1
encorafenib
1
elacestrant
1
brivaracetam
1
binimetinib
1
Valacyclovir
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Brain Neoplasms
×
Cytarabine
×
30 days
×
Clear all
No trials found.